食道がんの世界市場レポート 2024

食道がんの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.9%の年間複合成長率（CAGR）で19億4,000万米ドルに成長すると予想されます。予測期間で予想される成長は、食道がんの有病率の増加、医療に対する国民の意識の向上、医療インフラの強化、タバコとアルコールの持続的な摂取、食道腺がんの発生率の増加などの要因に起因すると考えられます。予測期間中に予想される顕著な動向には、治療技術の進歩、研究開発への投資の増加、精密医療の普及の拡大、標的療法の策定、臨床試験への関与の強化、学界・製薬会社・医療機関との連携の増加などが含まれます。

食道がんのケースの増加により、食道がん市場の成長が見込まれます。 食道がんは喉と胃をつなぐ管に影響を及ぼす悪性疾患で、発生率の上昇に伴い内視鏡検査、画像検査、生検などの診断処置の需要が高まっています。たとえば、2023年 2月のデータによると、食道腺がんの発生率は2021年の10万人あたり2.12人から2040年の10万人あたり3.86人へと82%増加し、年間増加率は3.2%になると予測されています。したがって、食道がんの出現の増加は、食道がん市場の成長の促進要因になると予想されます。

アルコール消費量の増加も、食道がん市場の成長を促進すると予想されます。アルコール摂取には、エタノールを含む飲料の摂取が含まれます。エタノールは、食道細胞のDNAに損傷を与える可能性がある既知の発がん物質であるアセトアルデヒドに代謝されます。慢性的なアルコール摂取は食道の内層に炎症や炎症を引き起こし、がんが発生しやすい環境を作り出す可能性があります。注目すべきは、2023年11月の薬物乱用・精神保健サービス局（SAMHSA）のデータで、2021年には米国の12歳以上の現在のアルコール使用者1億3,310万人のアルコール消費量が増加していることが明らかになったということです。このうち25.8％が過食を報告しました。過去1か月間飲酒しており、6.3パーセントが同じ期間に大量のアルコールを摂取したと報告しました。さらに、12歳以上の1,440万人が過去1年間にアルコール使用障害を経験しており、この年齢層の人々の5.3パーセントを占めています。したがって、アルコール摂取量の多さは食道がん市場の成長に寄与すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の食道がん市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 食道扁平上皮がん
• 食道腺がん
• その他
• 世界の食道がん市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 化学療法
• 標的療法
• その他
• 世界の食道がん市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 非経口
• その他
• 世界の食道がん市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の食道がん市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 在宅医療
• 専門センター
• その他

第7章 地域および国の分析

• 世界の食道がん市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の食道がん市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 食道がん市場の競合情勢
• 食道がん市場の企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Merck &Co. Inc
  • AbbVie Inc.

第31章 その他の大手および革新的な企業

• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline Plc.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Co Ltd.
• Boehringer Ingelheim International GmbH
• Gilead Sciences Inc.
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Servier Pharmaceuticals

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Esophageal cancer is a form of cancer originating in the cells that line the esophagus, the muscular tube responsible for transporting food and liquids from the neck to the stomach. This malignancy occurs when abnormal cells within the esophagus undergo uncontrolled growth, leading to the development of cancer.

The primary classifications of esophageal cancer include esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and other subtypes. Esophageal squamous-cell carcinoma specifically emerges from the squamous cells lining the esophagus. Treatment options encompass chemotherapy, targeted therapy, and various other approaches, which can be administered orally, parenterally, and through alternative methods. The distribution of treatment products occurs through channels such as hospital pharmacies, online pharmacies, and retail pharmacies, serving institutions such as hospitals, homecare services, specialty centers, and other healthcare facilities.

The esophageal cancer research report is one of a series of new reports from The Business Research Company that provides esophageal cancer market statistics, including the esophageal cancer industry's global market size, regional shares, competitors with a esophageal cancer market share, detailed esophageal cancer market segments, market trends and opportunities, and any further data you may need to thrive in the esophageal cancer industry. This esophageal cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry

The esophageal cancer market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.38 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historical period can be attributed to factors such as an increased incidence of cancer, advancements in healthcare infrastructure, a rise in alcohol consumption, an increased demand for preventive healthcare solutions, and a higher prevalence of esophageal adenocarcinoma.

The esophageal cancer market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth in the forecast period can be attributed to factors such as the increasing prevalence of esophageal cancer, greater public awareness of healthcare, enhancements in healthcare infrastructure, persistent tobacco and alcohol consumption, and a rising incidence of esophageal adenocarcinoma. Prominent trends expected in the forecast period encompass advancements in treatment technologies, augmented investment in research and development, a growing embrace of precision medicine, the formulation of targeted therapies, heightened involvement in clinical trials, and increased collaborations among academia, pharmaceutical companies, and healthcare institutions.

Anticipated growth in the esophageal cancer market is expected due to an increase in esophageal cancer cases. Esophageal cancer, a malignant condition impacting the tube connecting the throat to the stomach, prompts a higher demand for diagnostic procedures such as endoscopy, imaging tests, and biopsies as its incidence rises. For example, data from February 2023 indicates that the incidence rate of esophageal adenocarcinoma is projected to increase by 82% from 2.12 per 100,000 persons in 2021 to 3.86 per 100,000 persons in 2040, with a yearly growth rate of 3.2%. Therefore, the rising occurrence of esophageal cancer is expected to be a driving factor in the growth of the esophageal cancer market.

Increased consumption of alcohol is also anticipated to fuel the growth of the esophageal cancer market. Alcohol consumption involves ingesting beverages containing ethanol, which metabolizes into acetaldehyde, a known carcinogen that can damage DNA in esophageal cells. Chronic alcohol consumption can lead to inflammation and irritation in the esophageal lining, creating a conducive environment for cancer development. Notably, in November 2023, data from the Substance Abuse and Mental Health Services Administration (SAMHSA) revealed a rise in alcohol consumption among the 133.1 million current alcohol users aged 12 or older in the United States in 2021. Of these, 25.8 percent reported binge drinking in the past month, and 6.3 percent reported heavy alcohol use during the same period. Moreover, 14.4 million individuals aged 12 or older experienced an alcohol use disorder in the past year, constituting 5.3 percent of people in this age group. Consequently, high alcohol consumption is expected to contribute to the growth of the esophageal cancer market.

The approval of new drugs stands out as a significant trend gaining traction in the esophageal cancer market. Major companies within the esophageal cancer market are directing their efforts towards securing approvals for new drugs, a strategy aimed at enhancing their market position and gaining a competitive edge. An illustrative example is Bristol Myers Squibb, a US-based pharmaceutical company, which obtained approval from the U.S. Food and Drug Administration (FDA) in May 2022 for two of its products such as Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab). These products, primarily designed for individuals with advanced or metastatic esophageal squamous cell carcinoma (ESCC), received authorization based on favorable outcomes observed in Phase 3 clinical trials, demonstrating improved overall survival rates among treated patients.

A focus on precision medicine is also evident among major companies operating in the esophageal cancer market, as reflected in product launches. Precision medicine represents an innovative approach to medical treatment that tailors interventions based on individual patients' unique genetic, environmental, and lifestyle characteristics. Previse, a US-based biotechnology company, launched Esopredict in March 2023-a precision medicine solution empowering gastroenterologists to tailor approaches effectively for managing the risk of future cancer diagnoses. Esopredict utilizes The Esoscore derived from Barrett's esophagus cells to offer timely and accurate 5-year risk predictions for esophageal cancer. This groundbreaking product addresses an essential medical need by aiding healthcare providers in identifying patients at risk of progressing to high-grade dysplasia or esophageal cancer, thereby revolutionizing treatment approaches and significantly impacting the esophageal cancer market.

In January 2023, ProPhase Labs, Inc., a US-based next-generation biotech, genomics, and diagnostics company, acquired the rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test from Stella Diagnostics, Inc. This strategic move positions ProPhase Labs to facilitate healthcare providers in promptly initiating life-saving early treatment measures, such as ablation procedures to eliminate precancerous cells. Stella Diagnostics, Inc., a US-based molecular diagnostics organization, focuses on enhancing patient management strategies.

Major companies operating in the esophageal cancer market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.

North America was the largest region in the esophageal cancer market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the esophageal cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The esophageal cancer market consists of revenues earned by entities by providing esophageal cancer treatment services such as esophagectomy, palliative care, and brachytherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The esophageal cancer market consists of sales of fluorouracil, capecitabine, cisplatin, epirubicin, and docetaxel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Esophageal Cancer Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on esophageal cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for esophageal cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The esophageal cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Esophageal Squamous-Cell Carcinoma; Esophageal Adenocarcinoma; Other Types
• 2) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End Users: Hospitals; Homecare; Specialty Centers; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Esophageal Cancer Market Characteristics

3. Esophageal Cancer Market Trends And Strategies

4. Esophageal Cancer Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Esophageal Cancer Market Size and Growth

• 5.1. Global Esophageal Cancer Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Esophageal Cancer Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Esophageal Cancer Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Esophageal Cancer Market Segmentation

• 6.1. Global Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Esophageal Squamous-Cell Carcinoma
• Esophageal Adenocarcinoma
• Other Types
• 6.2. Global Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemotherapy
• Targeted Therapy
• Other Treatment Types
• 6.3. Global Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Specialty Centers
• Other End Users

7. Esophageal Cancer Market Regional And Country Analysis

• 7.1. Global Esophageal Cancer Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Esophageal Cancer Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Esophageal Cancer Market

• 8.1. Asia-Pacific Esophageal Cancer Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Esophageal Cancer Market

• 9.1. China Esophageal Cancer Market Overview
• 9.2. China Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Esophageal Cancer Market

• 10.1. India Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Esophageal Cancer Market

• 11.1. Japan Esophageal Cancer Market Overview
• 11.2. Japan Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Esophageal Cancer Market

• 12.1. Australia Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Esophageal Cancer Market

• 13.1. Indonesia Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Esophageal Cancer Market

• 14.1. South Korea Esophageal Cancer Market Overview
• 14.2. South Korea Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Esophageal Cancer Market

• 15.1. Western Europe Esophageal Cancer Market Overview
• 15.2. Western Europe Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Esophageal Cancer Market

• 16.1. UK Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Esophageal Cancer Market

• 17.1. Germany Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Esophageal Cancer Market

• 18.1. France Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Esophageal Cancer Market

• 19.1. Italy Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Esophageal Cancer Market

• 20.1. Spain Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Esophageal Cancer Market

• 21.1. Eastern Europe Esophageal Cancer Market Overview
• 21.2. Eastern Europe Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Esophageal Cancer Market

• 22.1. Russia Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Esophageal Cancer Market

• 23.1. North America Esophageal Cancer Market Overview
• 23.2. North America Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Esophageal Cancer Market

• 24.1. USA Esophageal Cancer Market Overview
• 24.2. USA Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Esophageal Cancer Market

• 25.1. Canada Esophageal Cancer Market Overview
• 25.2. Canada Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Esophageal Cancer Market

• 26.1. South America Esophageal Cancer Market Overview
• 26.2. South America Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Esophageal Cancer Market

• 27.1. Brazil Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Esophageal Cancer Market

• 28.1. Middle East Esophageal Cancer Market Overview
• 28.2. Middle East Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Esophageal Cancer Market

• 29.1. Africa Esophageal Cancer Market Overview
• 29.2. Africa Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Esophageal Cancer Market Competitive Landscape And Company Profiles

• 30.1. Esophageal Cancer Market Competitive Landscape
• 30.2. Esophageal Cancer Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann-La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck & Co. Inc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AbbVie Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Esophageal Cancer Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Sanofi S.A
• 31.4. Bristol-Myers Squibb Company
• 31.5. AstraZeneca PLC
• 31.6. GlaxoSmithKline Plc.
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Co Ltd.
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Gilead Sciences Inc.
• 31.11. Amgen Inc.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Astellas Pharma Inc.
• 31.14. Daiichi Sankyo Company Limited
• 31.15. Servier Pharmaceuticals

32. Global Esophageal Cancer Market Competitive Benchmarking

33. Global Esophageal Cancer Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Esophageal Cancer Market

35. Esophageal Cancer Market Future Outlook and Potential Analysis

• 35.1 Esophageal Cancer Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Esophageal Cancer Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Esophageal Cancer Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer